Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $149B | +$2.09B | 170 | 5.09% | Increased |
|
| 2 |
BlackRock
New York
| $133B | +$1.1B | 174 | 5.08% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $75.4B | +$873M | 137 | 5.16% | Increased |
|
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
| $62.5B | -$1.83B | 100 | 8.11% | Reduced |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $41.8B | -$1.05B | 114 | 4.61% | Reduced |
|
| 6 |
Wellington Management Group
Boston,
Massachusetts
| $32.3B | -$1.99B | 78 | 6.77% | Reduced |
|
| 7 |
Massachusetts Financial Services
Boston,
Massachusetts
| $26.5B | +$96.5M | 45 | 9.95% | Increased |
|
| 8 |
Geode Capital Management
Boston,
Massachusetts
| $24.5B | +$800M | 170 | 5.13% | Increased |
|
| 9 |
Bank of New York Mellon
New York
| $22.2B | -$475M | 144 | 5.72% | Reduced |
|
| 10 |
Northern Trust
Chicago,
Illinois
| $21.8B | -$7.56M | 165 | 4.89% | Reduced |
|
| 11 |
Capital Research Global Investors
Los Angeles,
California
| $20.2B | +$340M | 21 | 6.05% | Increased |
|
| 12 |
Morgan Stanley
New York
| $19.9B | +$2.02B | 181 | 4.62% | Increased |
|
| 13 |
Bank of America
Charlotte,
North Carolina
| $18.3B | +$54.4M | 167 | 2.63% | Increased |
|
| 14 |
Norges Bank
Oslo,
Norway
| $18.3B | -$49.8M | 83 | 5.1% | Reduced |
|
| 15 |
JP Morgan Chase
New York
| $16.7B | +$117M | 153 | 3.12% | Increased |
|
| 16 |
Capital World Investors
Los Angeles,
California
| $14.5B | -$1.82B | 25 | 3.25% | Reduced |
|
| 17 |
Wells Fargo
San Francisco,
California
| $14.3B | -$137M | 164 | 3.84% | Reduced |
|
| 18 |
Janus Henderson Group
London,
| $13.9B | -$230M | 61 | 7.1% | Reduced |
|
| 19 |
Invesco
Atlanta,
Georgia
| $13.4B | -$1.18B | 107 | 4.15% | Reduced |
|
| 20 |
Goldman Sachs
New York
| $12.9B | +$1.71B | 137 | 3.29% | Increased |
|
| 21 |
Nuveen
Charlotte,
North Carolina
| $12.8B | -$401M | 127 | 4.85% | Reduced |
|
| 22 |
Franklin Resources
San Mateo,
California
| $12.5B | -$92.3M | 53 | 6.57% | Reduced |
|
| 23 |
Ameriprise
Minneapolis,
Minnesota
| $10.4B | -$144M | 108 | 4.34% | Reduced |
|
| 24 |
Legal & General Group
London,
United Kingdom
| $10.4B | +$219M | 131 | 4.96% | Increased |
|
| 25 |
Capital International Investors
Los Angeles,
California
| $10.1B | -$177M | 17 | 3.41% | Reduced |
|